LCK Human Pre-designed siRNA Set A contains three designed siRNAs for LCK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lck-IN-2 (compound 12a) is an inhibitor of Lymphocyte-specific protein tyrosine kinase (Lck) with IC50 of 10.6 nM. Lck-IN-2 reveals efficacy in colon cancer cells with GI50s of 0.24-1.26 μM. Lck-IN-2 exhibits an apoptotic effect in Colo201 cells[1].

Lck-IN-3 (compound 7m) is an LCK inhibitor targeting acute lymphoblastic leukemia (ALL) that inhibits LCK phosphorylation. Lck-IN-3 can induce cell cycle arrest in the G2/M phase, leading to apoptosis in ALL cells[1].

LCLAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for LCLAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for LCMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCMT2 Human Pre-designed siRNA Set A contains three designed siRNAs for LCMT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCN1 Human Pre-designed siRNA Set A contains three designed siRNAs for LCN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCN10 Human Pre-designed siRNA Set A contains three designed siRNAs for LCN10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCN12 Human Pre-designed siRNA Set A contains three designed siRNAs for LCN12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCN2 Human Pre-designed siRNA Set A contains three designed siRNAs for LCN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCN6 Human Pre-designed siRNA Set A contains three designed siRNAs for LCN6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCN8 Human Pre-designed siRNA Set A contains three designed siRNAs for LCN8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCN9 Human Pre-designed siRNA Set A contains three designed siRNAs for LCN9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCOR Human Pre-designed siRNA Set A contains three designed siRNAs for LCOR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCORL Human Pre-designed siRNA Set A contains three designed siRNAs for LCORL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCP1 Human Pre-designed siRNA Set A contains three designed siRNAs for LCP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCP2 Human Pre-designed siRNA Set A contains three designed siRNAs for LCP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCT Human Pre-designed siRNA Set A contains three designed siRNAs for LCT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LCTL Human Pre-designed siRNA Set A contains three designed siRNAs for LCTL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDAH Human Pre-designed siRNA Set A contains three designed siRNAs for LDAH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDB1 Human Pre-designed siRNA Set A contains three designed siRNAs for LDB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDB2 Human Pre-designed siRNA Set A contains three designed siRNAs for LDB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDB3 Human Pre-designed siRNA Set A contains three designed siRNAs for LDB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDHA Human Pre-designed siRNA Set A contains three designed siRNAs for LDHA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDHB Human Pre-designed siRNA Set A contains three designed siRNAs for LDHB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDHC Human Pre-designed siRNA Set A contains three designed siRNAs for LDHC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDHD Human Pre-designed siRNA Set A contains three designed siRNAs for LDHD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDL-IN-1 (Compound 1) is an antioxidant, and is active against copper mediated LDL oxidation (IC50 = 52 μM). LDL-IN-1 is also an Acyl-CoA:cholesterol acyltransferase-1 and -2 (ACAT-1/2) inhibitor, with IC50s of 60 μM. LDL-IN-1 can be used for anti-atherosclerotic research[1].

LDL-IN-2 (compound 3) is an antioxidant against copper mediated low-density lipoproteins (LDL) oxidation[1].

LDL-IN-4 (Compound 2) inhibits human acyl-CoA:cholesterol acyltransferase-1 and -2 activities. LDL-IN-4 inhibits copper-mediated low density lipoprotein (LDL) oxidation, with an IC50 of 3 μM. LDL-IN-4 has anti-atherosclerotic biological activity[1].

LDLR Human Pre-designed siRNA Set A contains three designed siRNAs for LDLR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDLRAD1 Human Pre-designed siRNA Set A contains three designed siRNAs for LDLRAD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDLRAD2 Human Pre-designed siRNA Set A contains three designed siRNAs for LDLRAD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDLRAD3 Human Pre-designed siRNA Set A contains three designed siRNAs for LDLRAD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDLRAD4 Human Pre-designed siRNA Set A contains three designed siRNAs for LDLRAD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDLRAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for LDLRAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LDOC1 Human Pre-designed siRNA Set A contains three designed siRNAs for LDOC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lead (II) iodide can be used as detector material for photocell X-ray and γ-ray detection[1].

LEAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for LEAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LECT2 Human Pre-designed siRNA Set A contains three designed siRNAs for LECT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Helix pomatia lectin, biotin conjugate, is a carbohydrate-binding protein that is widely found in fungi, plants, and animals. Helix pomatia lectin, biotin conjugate is commonly used for characterizing, imaging, or targeting glycoconjugates, and is also a very useful tool for glycomics analysis[1].

Ledipasvir-d6 hydrochloride is deuterated labeled Ledipasvir acetone (HY-15602A). Ledipasvir acetone (GS-5885 acetone) is the active ingredient of Ledipasvir. Ledipasvir is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.

LEF1 Human Pre-designed siRNA Set A contains three designed siRNAs for LEF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LEFTY1 Human Pre-designed siRNA Set A contains three designed siRNAs for LEFTY1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LEFTY2 Human Pre-designed siRNA Set A contains three designed siRNAs for LEFTY2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LEMD1 Human Pre-designed siRNA Set A contains three designed siRNAs for LEMD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LEMD2 Human Pre-designed siRNA Set A contains three designed siRNAs for LEMD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LEMD3 Human Pre-designed siRNA Set A contains three designed siRNAs for LEMD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.